Cardiotoxicity Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies
- Ankit Nigam
- Jul 23, 2021
- 1 min read
Cardiotoxicity is a condition when there is damage to the heart muscle. It may be caused by chemotherapy drugs or medications concerning other diseases. As a result of cardiotoxicity, the heart becomes weaker and is unable to pump blood throughout the body.
DelveInsight's "Cardiotoxicity Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Cardiotoxicity, historical and forecasted epidemiology as well as the Cardiotoxicity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some Key Highlights from the Cardiotoxicity Market Report:
Cardiotoxicity was found in 39.6% of anthracycline-treated patients in a recent study (Sendon et al., 2020).
Cardiotoxicity also seen in patients who were taking anti-HER2 (43.5%), anthracycline and anti-HER2 (45.7%), TKI (50%), left breast radiotherapy (44.8%), and mediastinal radiotherapy (29.1%). (Sendon et al., 2020).
Around one-third of cancer patients who receive chemotherapy drugs including trastuzumab (Herceptin) and anthracyclines have heart cell damage (University of Michigan, n.d.).
Cardiotoxicity pipeline therapies include Annamycin (Moleculin Biotech), Camsirubicin (Monopar Therapeutics), and others.
Moleculin Biotech, Monopar Therapeutics, among others are the major pharmaceutical companies in the Cardiotoxicity market.
To gain more insights request sample @ https://www.delveinsight.com/sample-request/cardiotoxicity-market
Cardiotoxicity Epidemiology Segmentation
Various Cancer Total Incident Cases
Various Cancer Total Number of Patients taking Chemotherapy
Cardiotoxicity Total Number of Patients taking Specific Chemotherapy Agents
Cardiotoxicity Total Number of Patients
Cardiotoxicity Treatment Landscape
Dexrazoxan
ACE inhibitors
Beta-blockers
Diuretics
Digoxin
Vasodilators
To gain more insights request sample @ https://www.delveinsight.com/sample-request/cardiotoxicity-market
Some of the Cardiotoxicity Companies:
Moleculin Biotech
Monopar Therapeutics
And Many Others
Cardiotoxicity Pipeline Therapies:
Annamycin
Camsirubicin
And Many Others
To gain more insights request sample @ https://www.delveinsight.com/sample-request/cardiotoxicity-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.
Comments